research article

01

The history belongs to the components

The copper-associated tripeptide has literature reaching back to early tripeptide work in 1973. The thymosin beta family has its own sequence-characterization history, including a 43-residue sequence report in 1981. Those are distinct lines of research.

Putting components together in a commercial blend does not merge those histories into a study of the blend. A citation about one ingredient should be labeled as component research, with the exact material used in that paper kept visible.

Sources: [1] Early tripeptide research · 1973 · [2] Thymosin beta sequence research · 1981

02

Read the composition before the headline amount

The combined amount on a blend label is not the amount of every ingredient. Start with the listed composition and check the amount assigned to each component. A total alone is not enough to reproduce a material comparison.

There is no single molecular formula, molecular weight or sequence for a mixture of separate compounds. Adding residue strings together would describe an invented chain; adding molecular weights would not turn the blend into one molecule.

03

What evidence would apply to the finished blend?

A finished-blend claim requires evidence on that blend: its composition, formulation, analytical method and tested sample. Research on ingredients separately is useful background, but it does not establish a combined effect or a particular interaction between them.

When checking the batch report, look for how the laboratory identifies and measures components. Do not assume a single summary percentage reports every component’s amount. If the report does not answer the composition question, request the corresponding documentation.